| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | California State Teachers Retirement System | Institution | 244,286 | No Change | 0 | 0 % | $3,038,918 | $3,038,918 | $0 | 0.00 % | $0 | | | | | | News Article | History of California State Teachers Retirement System Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Ing Investment Management Europe B V | Institution | 82,315 | Added More | 10 | 0.01 % | $1,023,999 | $1,023,999 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ing Investment Management Europe B V Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janney Montgomery Scott Llc | Institution | | Sold All | -10,750 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Janney Montgomery Scott Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janus Capital Management Llc | Institution | 190,200 | Sold Some | -250,200 | -56.81 % | $2,366,088 | $2,366,088 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 397,658 | Added More | 372,489 | 1479.95 % | $5,189,437 | $4,946,866 | $-242,571 | -4.67 % | $-227,218 | | | | | | News Article | History of Amvescap Plc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 143,863 | Sold Some | -50,176 | -25.85 % | $1,877,412 | $1,789,656 | $-87,756 | -4.67 % | $30,607 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 760,871 | Added More | 16,672 | 2.24 % | $9,929,367 | $9,465,235 | $-464,131 | -4.67 % | $-10,170 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-11-13 | 13F-HR | Eastbourne Capital Management Llc | Institution | | Sold All | -17,200,000 | -100 % | | | | -3.71 % | $8,256,000 | | | | | | News Article | History of Eastbourne Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Acadia Trust Na | Institution | 500 | No Change | 0 | 0 % | $6,460 | $6,220 | $-240 | -3.71 % | $0 | | | | | | News Article | History of Acadia Trust Na Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 27,600 | New Holding | 27,600 | 100 % | $356,592 | $343,344 | $-13,248 | -3.71 % | $-13,248 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Argus Management Llc | Institution | | Sold All | -100,000 | -100 % | | | | -3.71 % | $48,000 | | | | | | News Article | History of Argus Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Atlas Capital Management Lp | Institution | 22,000 | New Holding | 22,000 | 100 % | $284,240 | $273,680 | $-10,560 | -3.71 % | $-10,560 | | | | | | News Article | History of Atlas Capital Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 12,937 | Sold Some | -57,061 | -81.51 % | $167,146 | $160,936 | $-6,210 | -3.71 % | $27,389 | | | | | | News Article | History of Bam Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bay Hill Capital Management Llc | No Data | | Sold All | -17,223 | -100 % | | | | -3.71 % | $8,267 | | | | | | News Article | History of Bay Hill Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 9,600 | Added More | 2,400 | 33.33 % | $124,032 | $119,424 | $-4,608 | -3.71 % | $-1,152 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital Guardian Trust Co | Institution | 675 | No Change | 0 | 0 % | $8,721 | $8,397 | $-324 | -3.71 % | $0 | | | | | | News Article | History of Capital Guardian Trust Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital Research Global Investors | Institution | 2,266,000 | New Holding | 2,266,000 | 100 % | $29,276,720 | $28,189,040 | $-1,087,680 | -3.71 % | $-1,087,680 | | | | | | News Article | History of Capital Research Global Investors Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 1,378,589 | Added More | 1,250,868 | 979.37 % | $17,811,370 | $17,149,647 | $-661,723 | -3.71 % | $-600,417 | | | | | | News Article | History of Citadel L P Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | 920,000 | New Holding | 920,000 | 100 % | $11,886,400 | $11,444,800 | $-441,600 | -3.71 % | $-441,600 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fidelity International Ltd | Institution | 500 | New Holding | 500 | 100 % | $6,460 | $6,220 | $-240 | -3.71 % | $-240 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 700 | No Change | 0 | 0 % | $9,044 | $8,708 | $-336 | -3.71 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 20,465,766 | Added More | 39,432 | 0.19 % | $264,417,697 | $254,594,129 | $-9,823,568 | -3.71 % | $-18,927 | | | | | | News Article | History of Fmr Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 45,000 | New Holding | 45,000 | 100 % | $581,400 | $559,800 | $-21,600 | -3.71 % | $-21,600 | | | | | | News Article | History of Galleon Management L P Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Healthcor Management L P | Institution | 1,300,000 | New Holding | 1,300,000 | 100 % | $16,796,000 | $16,172,000 | $-624,000 | -3.71 % | $-624,000 | | | | | | News Article | History of Healthcor Management L P Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Icahn Capital Lp | Institution | 12,971,328 | No Change | 0 | 0 % | $167,589,558 | $161,363,320 | $-6,226,237 | -3.71 % | $0 | | | | | | News Article | History of Icahn Capital Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 516,589 | Added More | 138,139 | 36.50 % | $6,674,330 | $6,426,367 | $-247,963 | -3.71 % | $-66,307 | | | | | | News Article | History of Ing Groep Nv Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 1,850,000 | Added More | 209,400 | 12.76 % | $23,902,000 | $23,014,000 | $-888,000 | -3.71 % | $-100,512 | | | | | | News Article | History of Millennium Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 2,015,024 | Added More | 1,589,431 | 373.46 % | $26,034,110 | $25,066,899 | $-967,212 | -3.71 % | $-762,927 | | | | | | News Article | History of Morgan Stanley Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 497,498 | Sold Some | -109 | -0.02 % | $6,427,674 | $6,188,875 | $-238,799 | -3.71 % | $52 | | | | | | News Article | History of Northern Trust Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 3,100 | New Holding | 3,100 | 100 % | $40,052 | $38,564 | $-1,488 | -3.71 % | $-1,488 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Partner Fund Management Lp | Institution | 4,198,585 | Added More | 1,561,221 | 59.19 % | $54,245,718 | $52,230,397 | $-2,015,321 | -3.71 % | $-749,386 | | | | | | News Article | History of Partner Fund Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Partner Investment Management Lp | Institution | 2,428,001 | Added More | 778,298 | 47.17 % | $31,369,773 | $30,204,332 | $-1,165,440 | -3.71 % | $-373,583 | | | | | | News Article | History of Partner Investment Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 200,000 | New Holding | 200,000 | 100 % | $2,584,000 | $2,488,000 | $-96,000 | -3.71 % | $-96,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 14,722 | Sold Some | -4,402 | -23.01 % | $190,208 | $183,142 | $-7,067 | -3.71 % | $2,113 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Raptor Capital Management Lp | No Data | | Sold All | -50,000 | -100 % | | | | -3.71 % | $24,000 | | | | | | News Article | History of Raptor Capital Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 40,600 | New Holding | 40,600 | 100 % | $524,552 | $505,064 | $-19,488 | -3.71 % | $-19,488 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 1,778,078 | Added More | 1,627,415 | 1080.16 % | $22,972,768 | $22,119,290 | $-853,477 | -3.71 % | $-781,159 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sigma Capital Management Llc | Institution | 350,000 | New Holding | 350,000 | 100 % | $4,522,000 | $4,354,000 | $-168,000 | -3.71 % | $-168,000 | | | | | | News Article | History of Sigma Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Sonar Capital Management Llc | Institution | | Sold All | -227,000 | -100 % | | | | -3.71 % | $108,960 | | | | | | News Article | History of Sonar Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Thales Fund Management Llc | Institution | | Sold All | -9,736 | -100 % | | | | -3.71 % | $4,673 | | | | | | News Article | History of Thales Fund Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 15,647 | Sold Some | -3,900 | -19.95 % | $202,159 | $194,649 | $-7,511 | -3.71 % | $1,872 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 426,100 | No Change | 0 | 0 % | $5,505,212 | $5,300,684 | $-204,528 | -3.71 % | $0 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 1,500 | No Change | 0 | 0 % | $19,380 | $18,660 | $-720 | -3.71 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Walleye Trading Llc | Institution | 2,896 | Added More | 649 | 28.88 % | $37,416 | $36,026 | $-1,390 | -3.71 % | $-312 | | | | | | News Article | History of Walleye Trading Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 105,000 | Added More | 40,000 | 61.53 % | $1,356,600 | $1,306,200 | $-50,400 | -3.71 % | $-19,200 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 18,993,802 | Sold Some | -550,210 | -2.81 % | $245,399,922 | $236,282,897 | $-9,117,025 | -3.71 % | $264,101 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-10-31 | 13F-HR | Peak6 Investments L P | Institution | 29,700 | Sold Some | -63,528 | -68.14 % | $373,626 | $369,468 | $-4,158 | -1.11 % | $8,894 | | | | | | News Article | History of Peak6 Investments L P Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 2,036 | Sold Some | -7,375 | -78.36 % | $25,613 | $25,328 | $-285 | -1.11 % | $1,033 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ascend Capital Llc | Institution | 100,000 | New Holding | 100,000 | 100 % | $1,258,000 | $1,244,000 | $-14,000 | -1.11 % | $-14,000 | | | | | | News Article | History of Ascend Capital Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 280,551 | Sold Some | -177,882 | -38.80 % | $3,529,332 | $3,490,054 | $-39,277 | -1.11 % | $24,903 | | | | | | News Article | History of Axa Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 1,421,026 | Added More | 132,700 | 10.30 % | $17,876,507 | $17,677,563 | $-198,944 | -1.11 % | $-18,578 | | | | | | News Article | History of Barclays Plc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | | Sold All | -25,663 | -100 % | | | | -1.11 % | $3,593 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital Fund Management S A | Institution | 3,115 | New Holding | 3,115 | 100 % | $39,187 | $38,751 | $-436 | -1.11 % | $-436 | | | | | | News Article | History of Capital Fund Management S A Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital One Financial Corp | Institution | | Sold All | -90 | -100 % | | | | -1.11 % | $13 | | | | | | News Article | History of Capital One Financial Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 30,175 | New Holding | 30,175 | 100 % | $379,602 | $375,377 | $-4,225 | -1.11 % | $-4,225 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 3,624 | Added More | 2,724 | 302.66 % | $45,590 | $45,083 | $-507 | -1.11 % | $-381 | | | | | | News Article | History of Credit Agricole S A Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | | Sold All | -103,001 | -100 % | | | | -1.11 % | $14,420 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | | Sold All | -53,058 | -100 % | | | | -1.11 % | $7,428 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dynamic Capital Management Llc | Institution | | Sold All | -16,600 | -100 % | | | | -1.11 % | $2,324 | | | | | | News Article | History of Dynamic Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geduld E E | Institution | 40,000 | New Holding | 40,000 | 100 % | $503,200 | $497,600 | $-5,600 | -1.11 % | $-5,600 | | | | | | News Article | History of Geduld E E Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 325,360 | Added More | 13,577 | 4.35 % | $4,093,029 | $4,047,478 | $-45,550 | -1.11 % | $-1,901 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 4,225,802 | Sold Some | -11,182,780 | -72.57 % | $53,160,589 | $52,568,977 | $-591,612 | -1.11 % | $1,565,589 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 348,459 | Added More | 213,459 | 158.11 % | $4,383,614 | $4,334,830 | $-48,784 | -1.11 % | $-29,884 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | | Sold All | -42,489 | -100 % | | | | -1.11 % | $5,948 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -16,760 | -100 % | | | | -1.11 % | $2,346 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Capital Management Inc | Institution | 760,859 | Added More | 319,100 | 72.23 % | $9,571,606 | $9,465,086 | $-106,520 | -1.11 % | $-44,674 | | | | | | News Article | History of Legg Mason Capital Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | | Sold All | -3,869 | -100 % | | | | -1.11 % | $542 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | | Sold All | -54,208 | -100 % | | | | -1.11 % | $7,589 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | 57,221 | Added More | 7,261 | 14.53 % | $719,840 | $711,829 | $-8,011 | -1.11 % | $-1,017 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 31,900 | Sold Some | -38,300 | -54.55 % | $401,302 | $396,836 | $-4,466 | -1.11 % | $5,362 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | 76,681 | Added More | 7,838 | 11.38 % | $964,647 | $953,912 | $-10,735 | -1.11 % | $-1,097 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 6,313 | Added More | 1,041 | 19.74 % | $79,418 | $78,534 | $-884 | -1.11 % | $-146 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Paradigm Asset Management Co Llc | Institution | 55,800 | New Holding | 55,800 | 100 % | $701,964 | $694,152 | $-7,812 | -1.11 % | $-7,812 | | | | | | News Article | History of Paradigm Asset Management Co Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Pine River Capital Management Lp | Institution | 18,400 | No Change | 0 | 0 % | $231,472 | $228,896 | $-2,576 | -1.11 % | $0 | | | | | | News Article | History of Pine River Capital Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Prescott Group Capital Management Llc | Institution | 27,050 | New Holding | 27,050 | 100 % | $340,289 | $336,502 | $-3,787 | -1.11 % | $-3,787 | | | | | | News Article | History of Prescott Group Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 14,811 | New Holding | 14,811 | 100 % | $186,322 | $184,249 | $-2,074 | -1.11 % | $-2,074 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 19,459 | Added More | 4,590 | 30.86 % | $244,794 | $242,070 | $-2,724 | -1.11 % | $-643 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Inc | Institution | 125 | Sold Some | -170 | -57.62 % | $1,573 | $1,555 | $-18 | -1.11 % | $24 | | | | | | News Article | History of Rbc Private Counsel Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 1,520,100 | Sold Some | -32,000 | -2.06 % | $19,122,858 | $18,910,044 | $-212,814 | -1.11 % | $4,480 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 20,933 | New Holding | 20,933 | 100 % | $263,337 | $260,407 | $-2,931 | -1.11 % | $-2,931 | | | | | | News Article | History of Sei Trust Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 4,680,033 | Added More | 160,784 | 3.55 % | $58,874,815 | $58,219,611 | $-655,205 | -1.11 % | $-22,510 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Wolverine Asset Management Llc | Institution | 26,358 | New Holding | 26,358 | 100 % | $331,584 | $327,894 | $-3,690 | -1.11 % | $-3,690 | | | | | | News Article | History of Wolverine Asset Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-13 | 2009-06-30 | 13F-HR/A | Caisse De Depot Et Placement Du Quebec | Institution | | Sold All | -13,070 | -100 % | | | | -1.11 % | $1,830 | | | | | | News Article | History of Caisse De Depot Et Placement Du Quebec Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Insurance Co | Institution | 38,261 | Sold Some | -2,770 | -6.75 % | $479,410 | $475,967 | $-3,443 | -0.71 % | $249 | | | | | | News Article | History of Allstate Insurance Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Retirement Plan | Institution | | Sold All | -12,541 | -100 % | | | | -0.71 % | $1,129 | | | | | | News Article | History of Allstate Retirement Plan Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Aviva Plc | Institution | 100,000 | New Holding | 100,000 | 100 % | $1,253,000 | $1,244,000 | $-9,000 | -0.71 % | $-9,000 | | | | | | News Article | History of Aviva Plc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 12,692 | Sold Some | -6,349 | -33.34 % | $159,031 | $157,888 | $-1,142 | -0.71 % | $571 | | | | | | News Article | History of Bank Of America Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 4,298,385 | Added More | 76,840 | 1.82 % | $53,858,764 | $53,471,909 | $-386,855 | -0.71 % | $-6,916 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 4,298,385 | Added More | 189,927 | 4.62 % | $53,858,764 | $53,471,909 | $-386,855 | -0.71 % | $-17,093 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Canada Pension Plan Investment Board | Institution | 10,000 | Added More | 8,500 | 566.66 % | $125,300 | $124,400 | $-900 | -0.71 % | $-765 | | | | | | News Article | History of Canada Pension Plan Investment Board Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 27,219 | New Holding | 27,219 | 100 % | $341,054 | $338,604 | $-2,450 | -0.71 % | $-2,450 | | | | | | News Article | History of Credit Suisse Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 1,250,000 | New Holding | 1,250,000 | 100 % | $15,662,500 | $15,550,000 | $-112,500 | -0.71 % | $-112,500 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Trust Advisors Lp | Institution | 188,365 | Sold Some | -83,336 | -30.67 % | $2,360,213 | $2,343,261 | $-16,953 | -0.71 % | $7,500 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 99,624 | No Change | 0 | 0 % | $1,248,289 | $1,239,323 | $-8,966 | -0.71 % | $0 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Grandfield And Dodd Llc | Institution | 20,900 | Sold Some | -1,400 | -6.27 % | $261,877 | $259,996 | $-1,881 | -0.71 % | $126 | | | | | | News Article | History of Grandfield And Dodd Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Hourglass Capital Llc | Institution | | Sold All | -12,200 | -100 % | | | | -0.71 % | $1,098 | | | | | | News Article | History of Hourglass Capital Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 67,450 | Added More | 38,000 | 129.03 % | $845,149 | $839,078 | $-6,071 | -0.71 % | $-3,420 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 165,753 | Added More | 130,114 | 365.08 % | $2,076,885 | $2,061,967 | $-14,918 | -0.71 % | $-11,710 | | | | | | News Article | History of Kbc Group Nv Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 87,842 | Added More | 36,297 | 70.41 % | $1,100,660 | $1,092,754 | $-7,906 | -0.71 % | $-3,267 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 720,584 | Added More | 284,184 | 65.12 % | $9,028,918 | $8,964,065 | $-64,853 | -0.71 % | $-25,577 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 36,340 | Added More | 10,980 | 43.29 % | $455,340 | $452,070 | $-3,271 | -0.71 % | $-988 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 254,418 | Added More | 88,200 | 53.06 % | $3,187,858 | $3,164,960 | $-22,898 | -0.71 % | $-7,938 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Qa3 Financial Llc | No Data | 100 | No Change | 0 | 0 % | $1,253 | $1,244 | $-9 | -0.71 % | $0 | | | | | | News Article | History of Qa3 Financial Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 205,048 | Added More | 141,691 | 223.63 % | $2,569,251 | $2,550,797 | $-18,454 | -0.71 % | $-12,752 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 27,800 | Sold Some | -9,000 | -24.45 % | $348,334 | $345,832 | $-2,502 | -0.71 % | $810 | | | | | | News Article | History of Russell Frank Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | San Francisco Sentry Investment Group | Institution | 2,000 | No Change | 0 | 0 % | $25,060 | $24,880 | $-180 | -0.71 % | $0 | | | | | | News Article | History of San Francisco Sentry Investment Group Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Fe Partners Llc | Institution | 25,359 | Added More | 3,172 | 14.29 % | $317,748 | $315,466 | $-2,282 | -0.71 % | $-285 | | | | | | News Article | History of Santa Fe Partners Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sector Gamma Asa | No Data | 240,000 | No Compare | | | $3,007,200 | $2,985,600 | $-21,600 | -0.71 % | | | | | | | News Article | History of Sector Gamma Asa Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Stafford Asset Management Llc | No Data | 10,600 | New Holding | 10,600 | 100 % | $132,818 | $131,864 | $-954 | -0.71 % | $-954 | | | | | | News Article | History of Stafford Asset Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 105,676 | Sold Some | -21,972 | -17.21 % | $1,324,120 | $1,314,609 | $-9,511 | -0.71 % | $1,977 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | | Sold All | -95,500 | -100 % | | | | -0.71 % | $8,595 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ubs Oconnor Llc | Institution | 350,000 | New Holding | 350,000 | 100 % | $4,385,500 | $4,354,000 | $-31,500 | -0.71 % | $-31,500 | | | | | | News Article | History of Ubs Oconnor Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 56,101 | No Change | 0 | 0 % | $702,946 | $697,896 | $-5,049 | -0.71 % | $0 | | | | | | News Article | History of United Services Automobile Association Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Westfield Capital Management Co Llc | Institution | 1,945,920 | New Holding | 1,945,920 | 100 % | $24,382,378 | $24,207,245 | $-175,133 | -0.71 % | $-175,133 | | | | | | News Article | History of Westfield Capital Management Co Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 18,514 | Added More | 5,474 | 41.97 % | $231,980 | $230,314 | $-1,666 | -0.71 % | $-493 | | | | | | News Article | History of World Asset Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 1,272,700 | Sold Some | -1,061,627 | -45.47 % | $15,743,299 | $15,832,388 | $89,089 | 0.56 % | $-74,314 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 381,900 | Added More | 321,118 | 528.31 % | $4,724,103 | $4,750,836 | $26,733 | 0.56 % | $22,478 | | | | | | News Article | History of Citigroup Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 27,523 | Added More | 14,134 | 105.56 % | $340,460 | $342,386 | $1,927 | 0.56 % | $989 | | | | | | News Article | History of Comerica Bank Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 2,750 | Added More | 400 | 17.02 % | $34,018 | $34,210 | $193 | 0.56 % | $28 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 163,324 | Added More | 7,561 | 4.85 % | $2,020,318 | $2,031,751 | $11,433 | 0.56 % | $529 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Kimelman And Baird Llc | Institution | 1,000 | No Change | 0 | 0 % | $12,370 | $12,440 | $70 | 0.56 % | $0 | | | | | | News Article | History of Kimelman And Baird Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Platte River Capital Llc | Institution | 240,570 | New Holding | 240,570 | 100 % | $2,975,851 | $2,992,691 | $16,840 | 0.56 % | $16,840 | | | | | | News Article | History of Platte River Capital Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | 3,144,084 | Sold Some | -109,114 | -3.35 % | $38,892,319 | $39,112,405 | $220,086 | 0.56 % | $-7,638 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Trevor Stewart Burton And Jacobsen Inc | Institution | 102,800 | No Change | 0 | 0 % | $1,271,636 | $1,278,832 | $7,196 | 0.56 % | $0 | | | | | | News Article | History of Trevor Stewart Burton And Jacobsen Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 237,040 | Sold Some | -81,895 | -25.67 % | $2,932,185 | $2,948,778 | $16,593 | 0.56 % | $-5,733 | | | | | | News Article | History of Ubs Ag Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Verizon Communications Inc | Institution | 13,068 | No Change | 0 | 0 % | $161,651 | $162,566 | $915 | 0.56 % | $0 | | | | | | News Article | History of Verizon Communications Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Wetherby Asset Management Inc | Institution | 147,032 | Sold Some | -2,189 | -1.46 % | $1,818,786 | $1,829,078 | $10,292 | 0.56 % | $-153 | | | | | | News Article | History of Wetherby Asset Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-06-30 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | | Sold All | -17,739 | -100 % | | | | 0.56 % | $-1,242 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-03-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 17,739 | No Change | 0 | 0 % | $219,431 | $220,673 | $1,242 | 0.56 % | $0 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2008-12-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 17,739 | Added More | 4,053 | 29.61 % | $219,431 | $220,673 | $1,242 | 0.56 % | $284 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 67,601 | New Holding | 67,601 | 100 % | $831,492 | $840,956 | $9,464 | 1.13 % | $9,464 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Bridgewater Associates Inc | Institution | 121,300 | Added More | 19,300 | 18.92 % | $1,491,990 | $1,508,972 | $16,982 | 1.13 % | $2,702 | | | | | | News Article | History of Bridgewater Associates Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Fan Asset Management Llc | Institution | 19,100 | No Change | 0 | 0 % | $234,930 | $237,604 | $2,674 | 1.13 % | $0 | | | | | | News Article | History of Fan Asset Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 69,161 | Sold Some | -332,137 | -82.76 % | $850,680 | $860,363 | $9,683 | 1.13 % | $-46,499 | | | | | | News Article | History of Federated Investors Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 18,200 | Sold Some | -42,800 | -70.16 % | $223,860 | $226,408 | $2,548 | 1.13 % | $-5,992 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 318,216 | Sold Some | -160,300 | -33.49 % | $3,914,057 | $3,958,607 | $44,550 | 1.13 % | $-22,442 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Twin Capital Management Inc | Institution | | Sold All | -99,250 | -100 % | | | | 1.13 % | $-13,895 | | | | | | News Article | History of Twin Capital Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | 35,200 | Sold Some | -1,753 | -4.74 % | $424,864 | $437,888 | $13,024 | 3.06 % | $-649 | | | | | | News Article | History of Blair William And Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 100 | Sold Some | -5,148 | -98.09 % | $1,207 | $1,244 | $37 | 3.06 % | $-1,905 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 34,197 | Sold Some | -11,950 | -25.89 % | $412,758 | $425,411 | $12,653 | 3.06 % | $-4,422 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Synovus Financial Corp | Institution | 9,500 | No Change | 0 | 0 % | $114,665 | $118,180 | $3,515 | 3.06 % | $0 | | | | | | News Article | History of Synovus Financial Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 741,095 | New Holding | 741,095 | 100 % | $8,945,017 | $9,219,222 | $274,205 | 3.06 % | $274,205 | | | | | | News Article | History of Tcw Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 43,300 | No Change | 0 | 0 % | $522,631 | $538,652 | $16,021 | 3.06 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 696,090 | Sold Some | -10,890 | -1.54 % | $8,401,806 | $8,659,360 | $257,553 | 3.06 % | $-4,029 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 13,500 | No Change | 0 | 0 % | $162,945 | $167,940 | $4,995 | 3.06 % | $0 | | | | | | News Article | History of Unionbancal Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - All Cap Growth Fund | Multi-Cap Growth | 56,020 | New Holding | 56,020 | 100 % | $676,161 | $696,889 | $20,727 | 3.06 % | $20,727 | | | | | | News Article | History of John Hancock Funds Ii - All Cap Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - Mid Cap Stock Fund | Mid-Cap Growth | 279,067 | New Holding | 279,067 | 100 % | $3,368,339 | $3,471,593 | $103,255 | 3.06 % | $103,255 | | | | | | News Article | History of John Hancock Funds Ii - Mid Cap Stock Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Kornitzer Capital Management Inc | Institution | 4,982,767 | Added More | 701,275 | 16.37 % | $59,942,687 | $61,985,621 | $2,042,934 | 3.40 % | $287,523 | | | | | | News Article | History of Kornitzer Capital Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 21,640 | No Change | 0 | 0 % | $260,329 | $269,202 | $8,872 | 3.40 % | $0 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 129,281 | Sold Some | -12,875 | -9.05 % | $1,555,250 | $1,608,256 | $53,005 | 3.40 % | $-5,279 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 15,504 | Sold Some | -456 | -2.85 % | $186,513 | $192,870 | $6,357 | 3.40 % | $-187 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 210,540 | Added More | 11,440 | 5.74 % | $2,532,796 | $2,619,118 | $86,321 | 3.40 % | $4,690 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Growth Etf | Multi-Cap Growth | 298 | Added More | 35 | 13.30 % | $3,585 | $3,707 | $122 | 3.40 % | $14 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Growth Etf Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf | Specialty & Misc | 160 | No Change | 0 | 0 % | $1,925 | $1,990 | $66 | 3.40 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 29,379 | Sold Some | -71,320 | -70.82 % | $345,497 | $365,475 | $19,978 | 5.78 % | $-48,498 | | | | | | News Article | History of Tradeworx Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 59,681 | Sold Some | -5,987 | -9.11 % | $728,705 | $742,432 | $13,727 | 1.88 % | $-1,377 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Dowling And Yahnke Inc | Institution | 20,325 | No Change | 0 | 0 % | $246,542 | $252,843 | $6,301 | 2.55 % | $0 | | | | | | News Article | History of Dowling And Yahnke Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR/A | Penn Mutual Life Insurance Co | Institution | | Sold All | -10,100 | -100 % | | | | 2.55 % | $-3,131 | | | | | | News Article | History of Penn Mutual Life Insurance Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 320,925 | Sold Some | -344,125 | -51.74 % | $3,892,820 | $3,992,307 | $99,487 | 2.55 % | $-106,679 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 21,360 | Sold Some | -1,000 | -4.47 % | $259,097 | $265,718 | $6,622 | 2.55 % | $-310 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 678,716 | New Holding | 678,716 | 100 % | $8,232,825 | $8,443,227 | $210,402 | 2.55 % | $210,402 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | General Electric Co | Institution | 971,210 | Added More | 86 | 0.00 % | $10,722,158 | $12,081,852 | $1,359,694 | 12.68 % | $120 | | | | | | News Article | History of General Electric Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR/A | Perkins Capital Management Inc | Institution | 13,100 | Added More | 1,000 | 8.26 % | $144,624 | $162,964 | $18,340 | 12.68 % | $1,400 | | | | | | News Article | History of Perkins Capital Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Sit Investment Associates Inc | Institution | 190,908 | Sold Some | -1,700 | -0.88 % | $2,107,624 | $2,374,896 | $267,271 | 12.68 % | $-2,380 | | | | | | News Article | History of Sit Investment Associates Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tocqueville Asset Management Lp | Institution | 62,000 | No Change | 0 | 0 % | $684,480 | $771,280 | $86,800 | 12.68 % | $0 | | | | | | News Article | History of Tocqueville Asset Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 5,565 | No Compare | | | $61,438 | $69,229 | $7,791 | 12.68 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund | Multi-Cap Growth | | Sold All | -703,453 | -100 % | | | | 12.68 % | $-984,834 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund | Multi-Cap Growth | | Sold All | -3,590,000 | -100 % | | | | 12.68 % | $-5,026,000 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Securities Fund - Agressive Growth Fund | Global Small/Mid-Cap Growth | | Sold All | -900,000 | -100 % | | | | 12.68 % | $-1,260,000 | | | | | | News Article | History of Fidelity Securities Fund - Agressive Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Sei Institutional Investments Trust - Siit Large Cap Fund | Large-Cap Core | | Sold All | -27,750 | -100 % | | | | 12.68 % | $-38,850 | | | | | | News Article | History of Sei Institutional Investments Trust - Siit Large Cap Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 62,836 | New Holding | 62,836 | 100 % | $693,709 | $781,680 | $87,970 | 12.68 % | $87,970 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 158,567 | Added More | 40,200 | 33.96 % | $1,809,249 | $1,972,573 | $163,324 | 9.02 % | $41,406 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Lyz Capital Advisors Llc | Institution | 11,051 | New Holding | 11,051 | 100 % | $126,092 | $137,474 | $11,383 | 9.02 % | $11,383 | | | | | | News Article | History of Lyz Capital Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Westend Advisors Llc | Institution | 3,750 | Added More | 1,317 | 54.13 % | $42,788 | $46,650 | $3,863 | 9.02 % | $1,357 | | | | | | News Article | History of Westend Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Growth Fund | Multi-Cap Growth | 12,629 | Sold Some | -923 | -6.81 % | $144,097 | $157,105 | $13,008 | 9.02 % | $-951 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Carl Domino Inc | Institution | 13,000 | No Change | 0 | 0 % | $148,330 | $161,720 | $13,390 | 9.02 % | $0 | | | | | | News Article | History of Carl Domino Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Hirtle Callaghan Co Inc | Institution | 800 | No Change | 0 | 0 % | $9,128 | $9,952 | $824 | 9.02 % | $0 | | | | | | News Article | History of Hirtle Callaghan Co Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 71 | No Change | 0 | 0 % | $869 | $883 | $14 | 1.63 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 9,411 | Added More | 1,963 | 26.35 % | $115,191 | $117,073 | $1,882 | 1.63 % | $393 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 1,975,700 | Added More | 1,696,800 | 608.39 % | $25,782,885 | $24,577,708 | $-1,205,177 | -4.67 % | $-1,035,048 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 249,531 | Added More | 190,400 | 321.99 % | $3,256,380 | $3,104,166 | $-152,214 | -4.67 % | $-116,144 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 806,300 | Added More | 665,206 | 471.46 % | $10,522,215 | $10,030,372 | $-491,843 | -4.67 % | $-405,776 | | | | | | News Article | History of Blackrock Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 181,027 | Added More | 42,249 | 30.44 % | $2,362,402 | $2,251,976 | $-110,426 | -4.67 % | $-25,772 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 570,003 | Added More | 83 | 0.01 % | $7,478,439 | $7,090,837 | $-387,602 | -5.18 % | $-56 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 470,278 | Added More | 68,917 | 17.17 % | $6,170,047 | $5,850,258 | $-319,789 | -5.18 % | $-46,864 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-21 | 2009-06-30 | 13F-HR/A | Rbc Trust Co International Ltd | No Data | | Sold All | -35,000 | -100 % | | | | -5.18 % | $23,800 | | | | | | News Article | History of Rbc Trust Co International Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-21 | 2009-03-31 | 13F-HR/A | Rbc Trust Co International Ltd | No Data | 35,000 | No Change | 0 | 0 % | $459,200 | $435,400 | $-23,800 | -5.18 % | $0 | | | | | | News Article | History of Rbc Trust Co International Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 139,400 | No Change | 0 | 0 % | $1,831,716 | $1,734,136 | $-97,580 | -5.32 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 122,000 | No Change | 0 | 0 % | $1,603,080 | $1,517,680 | $-85,400 | -5.32 % | $0 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Hanseatic Management Services Inc | Institution | 9,100 | New Holding | 9,100 | 100 % | $122,759 | $113,204 | $-9,555 | -7.78 % | $-9,555 | | | | | | News Article | History of Hanseatic Management Services Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 8,500 | No Change | 0 | 0 % | $114,665 | $105,740 | $-8,925 | -7.78 % | $0 | | | | | | News Article | History of Strs Ohio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Tompkins Trustco Inc | Institution | 100 | Sold Some | -100 | -50.00 % | $1,349 | $1,244 | $-105 | -7.78 % | $105 | | | | | | News Article | History of Tompkins Trustco Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-19 | 2009-08-31 | N-CSR | Goldman Sachs Trust - Goldman Sachs Concentrated Growth Fund | Gold Oriented | 45,440 | Sold Some | -166,270 | -78.53 % | $612,986 | $565,274 | $-47,712 | -7.78 % | $174,584 | | | | | | News Article | History of Goldman Sachs Trust - Goldman Sachs Concentrated Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Trust Co Of Vermont | Institution | 2,000 | No Change | 0 | 0 % | $27,780 | $24,880 | $-2,900 | -10.43 % | $0 | | | | | | News Article | History of Trust Co Of Vermont Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | | Sold All | -17,700 | -100 % | | | | -10.88 % | $26,904 | | | | | | News Article | History of Harris Financial Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Horrell Capital Management Inc | Institution | 70 | New Holding | 70 | 100 % | $977 | $871 | $-106 | -10.88 % | $-106 | | | | | | News Article | History of Horrell Capital Management Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 210,199 | Added More | 200 | 0.09 % | $2,934,378 | $2,614,876 | $-319,502 | -10.88 % | $-304 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Shell Asset Management Co | Institution | | Sold All | -5,489 | -100 % | | | | -10.82 % | $8,288 | | | | | | News Article | History of Shell Asset Management Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Financial Architects Inc | Institution | 500 | No Change | 0 | 0 % | $6,950 | $6,220 | $-730 | -10.50 % | $0 | | | | | | News Article | History of Financial Architects Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 147,872 | Sold Some | -1,736 | -1.16 % | $2,027,325 | $1,839,528 | $-187,797 | -9.26 % | $2,205 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-08 | 2009-03-31 | 13F-HR/A | Del Mar Asset Management Lp | Institution | | Sold All | -40,000 | -100 % | | | | -9.26 % | $50,800 | | | | | | News Article | History of Del Mar Asset Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-08 | 2008-12-31 | 13F-HR/A | Del Mar Asset Management Lp | Institution | 40,000 | New Holding | 40,000 | 100 % | $548,400 | $497,600 | $-50,800 | -9.26 % | $-50,800 | | | | | | News Article | History of Del Mar Asset Management Lp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 64,000 | New Holding | 64,000 | 100 % | $867,840 | $796,160 | $-71,680 | -8.25 % | $-71,680 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Health Care Ultrasector Profund | Health/Biotech | 584 | Added More | 312 | 114.70 % | $7,919 | $7,265 | $-654 | -8.25 % | $-349 | | | | | | News Article | History of Profunds - Health Care Ultrasector Profund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Technology Ultrasector Profund | Science & Tech | 7,072 | New Holding | 7,072 | 100 % | $95,896 | $87,976 | $-7,921 | -8.25 % | $-7,921 | | | | | | News Article | History of Profunds - Technology Ultrasector Profund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Denali Advisors Llc | Institution | 46,500 | Sold Some | -69,300 | -59.84 % | $615,660 | $578,460 | $-37,200 | -6.04 % | $55,440 | | | | | | News Article | History of Denali Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Money Market Fund | Specialty & Misc | | Sold All | -28,300 | -100 % | | | | -4.45 % | $16,414 | | | | | | News Article | History of Usaa Mutual Funds Trust - Money Market Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 56,100 | New Holding | 56,100 | 100 % | $730,422 | $697,884 | $-32,538 | -4.45 % | $-32,538 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 66,187 | Added More | 43,700 | 194.33 % | $908,086 | $823,366 | $-84,719 | -9.32 % | $-55,936 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 1,100 | No Change | 0 | 0 % | $15,092 | $13,684 | $-1,408 | -9.32 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 2,400 | Added More | 1,100 | 84.61 % | $32,928 | $29,856 | $-3,072 | -9.32 % | $-1,408 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Global Health Fund | Health/Biotech | 361 | Sold Some | -23 | -5.98 % | $4,953 | $4,491 | $-462 | -9.32 % | $29 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Global Health Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Heritage Capital Appreciation Trust - Heritage Capital Appreciation Trust | Specialty & Misc | 524,882 | New Holding | 524,882 | 100 % | $7,201,381 | $6,529,532 | $-671,849 | -9.32 % | $-671,849 | | | | | | News Article | History of Heritage Capital Appreciation Trust - Heritage Capital Appreciation Trust Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Kld 400 Social Index Fund | Specialty & Misc | 2,346 | Added More | 432 | 22.57 % | $32,187 | $29,184 | $-3,003 | -9.32 % | $-553 | | | | | | News Article | History of Ishares Trust - Ishares Kld 400 Social Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 46,693 | Added More | 9,143 | 24.34 % | $640,628 | $580,861 | $-59,767 | -9.32 % | $-11,703 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 622,700 | Added More | 17,900 | 2.95 % | $8,543,444 | $7,746,388 | $-797,056 | -9.32 % | $-22,912 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Mid Cap Growth Fund | Mid-Cap Growth | 233,000 | No Change | 0 | 0 % | $3,059,290 | $2,898,520 | $-160,770 | -5.25 % | $0 | | | | | | News Article | History of Harbor Funds - Harbor Mid Cap Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners All Cap Fund | Specialty & Misc | | Sold All | -441,759 | -100 % | | | | -5.25 % | $304,814 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners All Cap Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 1,200 | New Holding | 1,200 | 100 % | $15,756 | $14,928 | $-828 | -5.25 % | $-828 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 3,128 | Added More | 202 | 6.90 % | $41,071 | $38,912 | $-2,158 | -5.25 % | $-139 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Advantage Funds Inc - Global Alpha Fund | Global Flex Port | | Sold All | -787 | -100 % | | | | -2.50 % | $252 | | | | | | News Article | History of Advantage Funds Inc - Global Alpha Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Large Cap Bull 3x Shares | No Data | 14,442 | Added More | 10,486 | 265.06 % | $184,280 | $179,658 | $-4,621 | -2.50 % | $-3,356 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Large Cap Bull 3x Shares Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Mid Cap Bull 3x Shares | No Data | 1,374 | Added More | 573 | 71.53 % | $17,532 | $17,093 | $-440 | -2.50 % | $-183 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Mid Cap Bull 3x Shares Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 35,639 | Sold Some | -32,874 | -47.98 % | $454,754 | $443,349 | $-11,404 | -2.50 % | $10,520 | | | | | | News Article | History of Kbc Group Nv Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 900 | Sold Some | -59,801 | -98.51 % | $10,980 | $11,196 | $216 | 1.96 % | $-14,352 | | | | | | News Article | History of Credit Agricole S A Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 8,110 | Sold Some | -15,040 | -64.96 % | $102,510 | $100,888 | $-1,622 | -1.58 % | $3,008 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 103,001 | Sold Some | -144,099 | -58.31 % | $1,421,414 | $1,281,332 | $-140,081 | -9.85 % | $195,975 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-15 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 41,172 | New Holding | 41,172 | 100 % | $561,998 | $512,180 | $-49,818 | -8.86 % | $-49,818 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 4,221,545 | Sold Some | -226,895 | -5.10 % | $53,107,036 | $52,516,020 | $-591,016 | -1.11 % | $31,765 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 4,108,458 | Sold Some | -339,982 | -7.64 % | $51,684,402 | $51,109,218 | $-575,184 | -1.11 % | $47,597 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Lmp Small Cap Growth Fund | Small-Cap Growth | 13,020 | Sold Some | -2,520 | -16.21 % | $163,141 | $161,969 | $-1,172 | -0.71 % | $227 | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Lmp Small Cap Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 25,360 | Sold Some | -17,623 | -40.99 % | $317,761 | $315,478 | $-2,282 | -0.71 % | $1,586 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust - Growth Trust | Multi-Cap Growth | 140,960 | New Holding | 140,960 | 100 % | $1,802,878 | $1,753,542 | $-49,336 | -2.73 % | $-49,336 | | | | | | News Article | History of John Hancock Trust - Growth Trust Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | | Sold All | -51,350 | -100 % | | | | -2.73 % | $17,973 | | | | | | News Article | History of Advanced Series Trust - Ast Federated Aggressive Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 3,100 | Sold Some | -60,590 | -95.13 % | $39,649 | $38,564 | $-1,085 | -2.73 % | $21,207 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 136,000 | Added More | 65,400 | 92.63 % | $1,739,440 | $1,691,840 | $-47,600 | -2.73 % | $-22,890 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqinternational Growth Portfolio | Multi-Cap Growth | 34,819 | Added More | 4,800 | 15.98 % | $445,335 | $433,148 | $-12,187 | -2.73 % | $-1,680 | | | | | | News Article | History of Eq Advisors Trust - Eqinternational Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Series Fund Inc - Hartford Global Health Hls Fund | Health/Biotech | 186 | New Holding | 186 | 100 % | $2,379 | $2,314 | $-65 | -2.73 % | $-65 | | | | | | News Article | History of Hartford Series Fund Inc - Hartford Global Health Hls Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | John Hancock Funds Ii - Mid Cap Stock Fund | Mid-Cap Growth | | Sold All | -252,067 | -100 % | | | | -2.73 % | $88,223 | | | | | | News Article | History of John Hancock Funds Ii - Mid Cap Stock Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Fund | Mid-Cap Growth | 18,100 | No Change | 0 | 0 % | $231,499 | $225,164 | $-6,335 | -2.73 % | $0 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Cap Growth Equity Fund | Small-Cap Growth | 97,820 | Added More | 8,700 | 9.76 % | $1,251,118 | $1,216,881 | $-34,237 | -2.73 % | $-3,045 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Cap Growth Equity Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Mma Praxis Mutual Funds - Mma Praxis Growth Index Fund | Large-Cap Growth | 1,399 | Added More | 695 | 98.72 % | $17,893 | $17,404 | $-490 | -2.73 % | $-243 | | | | | | News Article | History of Mma Praxis Mutual Funds - Mma Praxis Growth Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Biotechnology | Health/Biotech | 8,424 | New Holding | 8,424 | 100 % | $107,743 | $104,795 | $-2,948 | -2.73 % | $-2,948 | | | | | | News Article | History of Profunds - Profund Vp Biotechnology Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Health Care | Health/Biotech | 4,032 | New Holding | 4,032 | 100 % | $51,569 | $50,158 | $-1,411 | -2.73 % | $-1,411 | | | | | | News Article | History of Profunds - Profund Vp Health Care Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund | Mid-Cap Core | 56,700 | Added More | 5,300 | 10.31 % | $725,193 | $705,348 | $-19,845 | -2.73 % | $-1,855 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Large Cap Growth | Large-Cap Growth | 7,386 | No Change | 0 | 0 % | $94,467 | $91,882 | $-2,585 | -2.73 % | $0 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Large Cap Growth Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Balanced Portfolio | Flexible Portfolio | 49,799 | Added More | 1,720 | 3.57 % | $636,929 | $619,500 | $-17,430 | -2.73 % | $-602 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Balanced Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Anchor Series Trust - Asset Allocation Portfolio | Specialty & Misc | | Sold All | -500 | -100 % | | | | - % | | | | | | | News Article | History of Anchor Series Trust - Asset Allocation Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Anchor Series Trust - Growth Portfolio | Multi-Cap Growth | | Sold All | -1,800 | -100 % | | | | - % | | | | | | | News Article | History of Anchor Series Trust - Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 14 | No Change | 0 | 0 % | | $174 | | - % | | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -28,500 | -100 % | | | | - % | | | | | | | News Article | History of Mml Series Investment Fund - Mml Mid Cap Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Small Cap Growth Equity Fund | Small-Cap Growth | 49,700 | Added More | 5,880 | 13.41 % | | $618,268 | | - % | | | | | | | News Article | History of Mml Series Investment Fund - Mml Small Cap Growth Equity Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Large-Cap Growth Index Portfolio | No Data | 379 | No Compare | | | | $4,715 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Large-Cap Growth Index Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -1,644,359 | -100 % | | | | - % | | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | | Sold All | -102,439 | -100 % | | | | -0.55 % | $7,171 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 25,169 | Sold Some | -44,795 | -64.02 % | $316,123 | $313,102 | $-3,020 | -0.95 % | $5,375 | | | | | | News Article | History of Amvescap Plc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 20,426,334 | Added More | 646,053 | 3.26 % | $256,554,755 | $254,103,595 | $-2,451,160 | -0.95 % | $-77,526 | | | | | | News Article | History of Fmr Corp Ownership Of Amylin Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 166,218 | Added More | 27,529 | 19.84 % | $2,087,698 | $2,067,752 | $-19,946 | -0.95 % | $-3,303 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Buffalo Funds - Buffalo Science And Technology Fund | Science & Tech | 251,700 | Added More | 55,400 | 28.22 % | $3,171,420 | $3,131,148 | $-40,272 | -1.26 % | $-8,864 | | | | | | News Article | History of Buffalo Funds - Buffalo Science And Technology Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Destiny Portfolios - Diversified Stock Fund | Large-Cap Growth | 525,000 | No Change | 0 | 0 % | $6,615,000 | $6,531,000 | $-84,000 | -1.26 % | $0 | | | | | | News Article | History of Fidelity Destiny Portfolios - Diversified Stock Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -420 | -100 % | | | | -1.26 % | $67 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund | Large-Cap Core | 3,700 | New Holding | 3,700 | 100 % | $46,620 | $46,028 | $-592 | -1.26 % | $-592 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Growth Fund | Large-Cap Growth | | Sold All | -271,169 | -100 % | | | | -1.26 % | $43,387 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 1,697 | Added More | 129 | 8.22 % | $21,382 | $21,111 | $-272 | -1.26 % | $-21 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Money Market Fund | Specialty & Misc | 28,300 | Added More | 1,500 | 5.59 % | $356,580 | $352,052 | $-4,528 | -1.26 % | $-240 | | | | | | News Article | History of Usaa Mutual Funds Trust - Money Market Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -56,100 | -100 % | | | | -1.26 % | $8,976 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Index Series Inc - Calvert Social Index Fund | Multi-Cap Core | 2,319 | Added More | 101 | 4.55 % | $29,938 | $28,848 | $-1,090 | -3.64 % | $-47 | | | | | | News Article | History of Calvert Social Index Series Inc - Calvert Social Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Growth Fund | Multi-Cap Growth | | Sold All | -13,913 | -100 % | | | | -3.64 % | $6,539 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Forum Funds - Absolute Strategies Fund | Equity Mkt Neutral Funds | 50,000 | New Holding | 50,000 | 100 % | $645,500 | $622,000 | $-23,500 | -3.64 % | $-23,500 | | | | | | News Article | History of Forum Funds - Absolute Strategies Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 576,048 | Sold Some | -24,416 | -4.06 % | $7,436,780 | $7,166,037 | $-270,743 | -3.64 % | $11,476 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Growth Index Fund | Multi-Cap Growth | 287,779 | Added More | 9,354 | 3.35 % | $3,715,227 | $3,579,971 | $-135,256 | -3.64 % | $-4,396 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Growth Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Index Fund | Specialty & Misc | 69,008 | Sold Some | -546 | -0.78 % | $890,893 | $858,460 | $-32,434 | -3.64 % | $257 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 8,837 | Sold Some | -341 | -3.71 % | $114,086 | $109,932 | $-4,153 | -3.64 % | $160 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 40,208 | Added More | 4,195 | 11.64 % | $519,085 | $500,188 | $-18,898 | -3.64 % | $-1,972 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Growth Index Fund | Mid-Cap Growth | 241,912 | Added More | 37,561 | 18.38 % | $3,123,084 | $3,009,385 | $-113,699 | -3.64 % | $-17,654 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Growth Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Index Fund | Mid-Cap Core | 212,037 | Sold Some | -9,723 | -4.38 % | $2,737,398 | $2,637,740 | $-99,657 | -3.64 % | $4,570 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Large Cap Growth Portfolio | Large-Cap Growth | 51,560 | New Holding | 51,560 | 100 % | $665,640 | $641,406 | $-24,233 | -3.64 % | $-24,233 | | | | | | News Article | History of Seasons Series Trust - Large Cap Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Mid Cap Growth Portfolio | Mid-Cap Growth | 10,619 | New Holding | 10,619 | 100 % | $137,091 | $132,100 | $-4,991 | -3.64 % | $-4,991 | | | | | | News Article | History of Seasons Series Trust - Mid Cap Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sti Classic Funds - Emerging Growth Stock Fund | Mid-Cap Growth | | Sold All | -24,800 | -100 % | | | | -3.64 % | $11,656 | | | | | | News Article | History of Sti Classic Funds - Emerging Growth Stock Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 744,199 | Added More | 2,585 | 0.34 % | $9,607,609 | $9,257,836 | $-349,774 | -3.64 % | $-1,215 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Grizzly Short Fund | No Data | 96,756 | New Holding | 96,756 | 100 % | $1,256,860 | $1,203,645 | $-53,216 | -4.23 % | $-53,216 | | | | | | News Article | History of Leuthold Funds Inc - Grizzly Short Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Mgi Funds - Mgi Us Large Cap Growth Equity Fund | Large-Cap Growth | 67,200 | New Holding | 67,200 | 100 % | $872,928 | $835,968 | $-36,960 | -4.23 % | $-36,960 | | | | | | News Article | History of Mgi Funds - Mgi Us Large Cap Growth Equity Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSR | Sit Mid Cap Growth Fund Inc - Sit Mid Cap Growth Fund Inc | Multi-Cap Growth | 50,600 | No Change | 0 | 0 % | $657,294 | $629,464 | $-27,830 | -4.23 % | $0 | | | | | | News Article | History of Sit Mid Cap Growth Fund Inc - Sit Mid Cap Growth Fund Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSR | Sit Mutual Funds Inc - Sit International Growth Fund | Multi-Cap Growth | 50,600 | No Change | 0 | 0 % | $657,294 | $629,464 | $-27,830 | -4.23 % | $0 | | | | | | News Article | History of Sit Mutual Funds Inc - Sit International Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSR | Sit Mutual Funds Inc - Sit Small Cap Growth Fund | Mid-Cap Growth | 28,100 | Sold Some | -22,100 | -44.02 % | $365,019 | $349,564 | $-15,455 | -4.23 % | $12,155 | | | | | | News Article | History of Sit Mutual Funds Inc - Sit Small Cap Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | | Sold All | -6,606 | -100 % | | | | -4.23 % | $3,633 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | 11,589 | Sold Some | -5,965 | -33.98 % | $150,541 | $144,167 | $-6,374 | -4.23 % | $3,281 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard 500 Index Fund | S&P 500 Index | | Sold All | -152,582 | -100 % | | | | -4.23 % | $83,920 | | | | | | News Article | History of Vanguard Index Funds - Vanguard 500 Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 728,675 | New Holding | 728,675 | 100 % | $9,465,488 | $9,064,717 | $-400,771 | -4.23 % | $-400,771 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 575,754 | New Holding | 575,754 | 100 % | $7,479,044 | $7,162,380 | $-316,665 | -4.23 % | $-316,665 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 1,278,861 | New Holding | 1,278,861 | 100 % | $16,612,404 | $15,909,031 | $-703,374 | -4.23 % | $-703,374 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 65,090 | Added More | 13,000 | 24.95 % | $845,519 | $809,720 | $-35,800 | -4.23 % | $-7,150 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 51,290 | Sold Some | -800 | -1.53 % | $666,257 | $638,048 | $-28,210 | -4.23 % | $440 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Touchstone Funds Group Trust - Touchstone Healthcare And Biotechnology Fund | Health/Biotech | 20,100 | Added More | 1,690 | 9.17 % | $263,310 | $250,044 | $-13,266 | -5.03 % | $-1,115 | | | | | | News Article | History of Touchstone Funds Group Trust - Touchstone Healthcare And Biotechnology Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Vanguard Morgan Growth Fund - Vanguard Morgan Growth Fund | Multi-Cap Growth | | Sold All | -344,200 | -100 % | | | | -5.03 % | $227,172 | | | | | | News Article | History of Vanguard Morgan Growth Fund - Vanguard Morgan Growth Fund Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | 42,489 | Added More | 11,579 | 37.46 % | $561,705 | $528,563 | $-33,141 | -5.90 % | $-9,032 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio | No Data | | Sold All | -64,600 | -100 % | | | | -5.90 % | $50,388 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio Ownership Of Amylin Pharmaceuticals Inc |
RSS feed for AMLN